1. a) Determining if a prescriber or dispenser is properly using the ILPMP. If it is considered by the ILPMP staff that any registered user is not using the ILPMP responsibly, an investigator from DFPR's Bureau of Drug Compliance will be contacted in order to investigate the issue. If the ILPMP supervisor considers the issue serious and of immediate concern, the registered user's ILPMP access may be suspended.
2. b) Determining if a non-registered person or entity is attempting to access the system. The ILPMP staff shall report the situation to the Department and to one or more of the following entities:
3. 1) Illinois law enforcement agency;
4. 2) Illinois regulatory entity;
5. 3) federal agency; or
6. 4) an agency in another state.

The Department's Bureau of Pharmacy and Clinical Support Systems or successor shall establish, operate, maintain, and enhance a stand-alone, one-to-one secure link with the necessary encrypted software that shall function as a prescriber and dispenser inquiry system to be known as the Illinois Prescription Monitoring Program (ILPMP). The Bureau must install a system to track each use of the ILPMP. The tracking system will only be utilized for the following purposes:

(Source: Amended at 47 Ill. Reg. 13500, effective September 8, 2023)